AVIR Chart
- 52-Week Range: $5.33 - $44.59
- Market Capitalization: $623.60M
- Short Percentage: 0%
- Target Price: $7.50
- Shares Outstanding: 83.26M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
AVIR released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Atea Pharmaceuticals, Inc. (AVIR) CEO Jean-Pierre Sommadossi on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 28th
- Dow Jones Newswires: Atea Pharma stock jumps as earnings rise, potential COVID-19 therapy advancesMarket Watch | February 28th
- Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business UpdateGlobeNewsWire | February 28th
- Atea Pharmaceuticals to Present at 11th Annual SVB Leerink Global Healthcare ConferenceGlobeNewsWire | February 9th
Company Info
Website: https://ateapharma.com
Address: 125 Summer Street, Boston, MA, United States, 02110
Sector: Healthcare
Industry: Biotechnology
Full time employees: 59
Address: 125 Summer Street, Boston, MA, United States, 02110
Sector: Healthcare
Industry: Biotechnology
Full time employees: 59
$AVIR bear trap dude
$AVIR called it
$AVIR 50% chance this will go up or down. I am a professional guys.
$AVIR is being added
$AVIR let's gooooooo
$AVIR watch this fly!!!!
$AVIR upupup!
$AVIR has just been halted from trading.
$AVIR has just been halted from trading.
$AVIR who here can't stand the CEO?